News coverage about NutriSystem (NASDAQ:NTRI) has been trending somewhat positive this week, Accern reports. Accern identifies positive and negative news coverage by reviewing more than 20 million blog and news sources in real-time. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. NutriSystem earned a coverage optimism score of 0.02 on Accern’s scale. Accern also assigned news coverage about the company an impact score of 45.4881051696961 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the company’s share price in the near term.
Here are some of the media stories that may have effected Accern Sentiment’s rankings:
- Latest Valuation: NutriSystem Inc (NASDAQ: NTRI) (tradingnewsnow.com)
- Weird But Effective Stocks:- KeyCorp (NYSE:KEY), Nutrisystem, Inc. (NASDAQ:NTRI), Tyson Foods, Inc. (NYSE:TSN) (thestreetpoint.com)
- Beta Factor valuation: Berkshire Hills Bancorp, Inc. (NYSE:BHLB), Nutrisystem, Inc. (NASDAQ:NTRI), Quotient … (stocksnewspoint.com)
- Comparing NutriSystem (NTRI) & Blue Apron (APRN) (americanbankingnews.com)
- Nutrisystem CEO: Lessons learned from college to the C-suite (bizjournals.com)
A number of equities analysts have issued reports on NTRI shares. B. Riley set a $52.00 price target on NutriSystem and gave the stock a “buy” rating in a research report on Wednesday, February 28th. Argus downgraded NutriSystem from a “buy” rating to a “hold” rating in a research report on Tuesday, March 20th. BidaskClub downgraded NutriSystem from a “hold” rating to a “sell” rating in a research report on Friday, February 23rd. Zacks Investment Research upgraded NutriSystem from a “hold” rating to a “buy” rating and set a $38.00 price target on the stock in a research report on Wednesday, May 9th. Finally, Barrington Research cut NutriSystem from an “outperform” rating to a “market perform” rating in a report on Tuesday, February 27th. Two research analysts have rated the stock with a sell rating, two have assigned a hold rating and six have issued a buy rating to the company’s stock. The company presently has an average rating of “Hold” and an average target price of $48.71.
Shares of NutriSystem stock traded up $0.60 during mid-day trading on Monday, reaching $37.30. 11,959 shares of the stock traded hands, compared to its average volume of 696,859. NutriSystem has a fifty-two week low of $26.06 and a fifty-two week high of $67.95. The stock has a market capitalization of $1.09 billion, a P/E ratio of 18.99, a PEG ratio of 1.00 and a beta of 1.17.
NutriSystem (NASDAQ:NTRI) last announced its earnings results on Monday, April 30th. The company reported $0.09 EPS for the quarter, beating analysts’ consensus estimates of $0.06 by $0.03. NutriSystem had a return on equity of 42.69% and a net margin of 7.65%. The business had revenue of $210.60 million during the quarter, compared to analysts’ expectations of $206.85 million. During the same quarter in the prior year, the firm earned $0.25 earnings per share. The business’s revenue was down 1.0% compared to the same quarter last year. equities analysts forecast that NutriSystem will post 2.09 EPS for the current fiscal year.
The company also recently announced a quarterly dividend, which was paid on Monday, May 21st. Shareholders of record on Thursday, May 10th were issued a dividend of $0.25 per share. The ex-dividend date was Wednesday, May 9th. This represents a $1.00 dividend on an annualized basis and a dividend yield of 2.68%. NutriSystem’s payout ratio is currently 51.02%.
Nutrisystem, Inc, together with its subsidiaries, provides weight management products and services for women and men in the United States. The company offers weight loss programs that consist primarily of a pre-packaged food program, digital tools, and counseling. It also provides Nutrisystem Lean13 program, which provides weight loss, and support and counseling services; the South Beach Diet, a weight-loss program; and Nutrisystem 5-day kit, a ?D' kit that offers individuals with or at risk of type 2 diabetes.
Receive News & Ratings for NutriSystem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NutriSystem and related companies with MarketBeat.com's FREE daily email newsletter.